Home » Authors » James Etheridge

Articles by James Etheridge

Created: Public-Private Fund For Early Investing In France

Feb. 15, 2006

By James Etheridge

Hybrigenics Gains Rights To Theramex’s Inecalcitol

Feb. 15, 2006

By James Etheridge

MAT BioPharma, Pierre Fabre Enter Antibody Collaboration

Feb. 15, 2006

By James Etheridge

GemacBio Has Successful Phase IIa Trial Of MS Drug

Feb. 8, 2006

By James Etheridge

CombinatoRx, Fovea Sign Deal For New Ophthalmology Drugs

Feb. 8, 2006

By James Etheridge

GemacBio Has Successful Phase IIa Trial Of MS Drug

Feb. 8, 2006

By James Etheridge

CombinatoRx, Fovea Sign Deal For New Ophthalmology Drugs

Feb. 8, 2006

By James Etheridge

DBV Technologies Raises EUR12M In Second Round

Jan. 25, 2006

By James Etheridge

DBV Technologies Raises EUR12M In Second Round

Jan. 25, 2006

By James Etheridge

LibraGen Initiates Agreement With Pierre Fabre Médicament

Jan. 11, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...